Edition:
United States

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

162.37USD
16 Feb 2018
Change (% chg)

$-1.23 (-0.75%)
Prev Close
$163.60
Open
$160.01
Day's High
$163.75
Day's Low
$159.40
Volume
172,236
Avg. Vol
291,721
52-wk High
$195.97
52-wk Low
$57.17

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.967
Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 7 0.00 0.00 0.00 --
Quarter Ending Jun-18 7 0.00 0.00 0.00 --
Year Ending Dec-18 13 10.75 57.40 0.00 55.01
Earnings (per share)
Quarter Ending Mar-18 7 -2.00 -1.79 -2.26 --
Quarter Ending Jun-18 7 -2.19 -1.79 -2.74 --
Year Ending Dec-18 13 -8.28 -6.59 -10.76 -4.45
LT Growth Rate (%) 1 -15.20 -15.20 -15.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta 3.09 0.82 0.81
Price to Sales (TTM) -- 140.57 8.57
Price to Book (MRQ) 30.46 18.76 5.14
Price to Tangible Book (MRQ) 33.32 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions -- 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -71.65 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -64.06 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 4.98 6.17 3.38
LT Debt to Equity (MRQ) 0.00 16.64 11.85
Total Debt to Equity (MRQ) 0.00 18.80 15.12
Interest Coverage (TTM) -- -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -- -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -- -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -- -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,305,201 819,569,446
Net Income/Employee (TTM) -1,900,741 -626,600 95,804,981
Receivable Turnover (TTM) -- 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -74.66 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -83.42 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -83.61 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 305
Total Shares Held: 46,651,039
3 Mo. Net Change: 4,744,095
# New Positions: 74
# Closed Positions: 34
# Increased Positions: 174
# Reduced Positions: 110
# Net Buyers: 64
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.